| scholarly article | Q13442814 |
| P2093 | author name string | Arthur H Wolintz | |
| Douglas R Lazzaro | |||
| Sofya Glazman | |||
| Mohammedyusuf E Hajee | |||
| Eric M Shrier | |||
| Ivan G Bodis-Wollner | |||
| Wayne F March | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 737-741 | |
| P577 | publication date | 2009-06-01 | |
| P1433 | published in | JAMA Ophthalmology | Q4787301 |
| P1476 | title | Inner retinal layer thinning in Parkinson disease. | |
| P478 | volume | 127 |
| Q35764753 | A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography |
| Q34579980 | Adaptation to experimental jet-lag in R6/2 mice despite circadian dysrhythmia |
| Q34990005 | Alterations in energy metabolism, neuroprotection and visual signal transduction in the retina of Parkinsonian, MPTP-treated monkeys |
| Q41506436 | An adaptive grid for graph-based segmentation in retinal OCT. |
| Q33915815 | Analysis of macular OCT images using deformable registration. |
| Q47096860 | Analysis of the Retinal Nerve Fiber Layer Thickness in Alzheimer Disease and Mild Cognitive Impairment |
| Q30804742 | Application of an OCT data-based mathematical model of the foveal pit in Parkinson disease. |
| Q64122136 | Assessing Retinal Structure in Patients with Parkinson's Disease |
| Q37011166 | Assessment of candidate ocular biomarkers of ageing in a South African adult population: relationship with chronological age and systemic biomarkers |
| Q39827858 | Biomarkers in Parkinson‘s Disease: A Funder‘s Perspective |
| Q35097665 | Changes of retina are not involved in the genesis of visual hallucinations in Parkinson's disease |
| Q48671700 | Characterization of structure and function of the mouse retina using pattern electroretinography, pupil light reflex, and optical coherence tomography |
| Q41738955 | Collaborative SDOCT Segmentation and Analysis Software |
| Q49958990 | Color discrimination errors associate with axial motor impairments in Parkinson's disease |
| Q48212516 | Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson's disease |
| Q40066891 | Cortical information flow in Parkinson's disease: a composite network/field model. |
| Q48177291 | Current aspects of cognitive neurophysiology of Parkinson disease: an introduction |
| Q34399834 | Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography. |
| Q44875009 | Development of a prediction formula of Parkinson disease severity by optical coherence tomography |
| Q41231938 | Diagnostic capability of retinal thickness measures in diabetic peripheral neuropathy. |
| Q38690675 | Direct and indirect effects of attention and visual function on gait impairment in Parkinson's disease: influence of task and turning |
| Q34936735 | Discharge responses of the optic tract to flash stimuli in Parkinson's disease |
| Q48285808 | Discriminative power of different nonmotor signs in early Parkinson's disease. A case-control study |
| Q37733707 | Dopamine: A Modulator of Circadian Rhythms in the Central Nervous System |
| Q36104129 | Evaluation of Retinal Vessel Morphology in Patients with Parkinson's Disease Using Optical Coherence Tomography |
| Q47998447 | Evaluation of thickness of retinal nerve fiber layer, ganglion cell layer, and choroidal thickness in essential tremor: can eyes be a clue for neurodegeneration? |
| Q51751226 | Focal loss volume of ganglion cell complex in diabetic neuropathy. |
| Q64874071 | Functional and morphological assessment of ocular structures and follow-up of patients with early-stage Parkinson's disease |
| Q90390916 | Genome-wide association analyses identify 139 loci associated with macular thickness in the UK Biobank cohort |
| Q59807190 | High-Order Visual Processing, Visual Symptoms, and Visual Hallucinations: A Possible Symptomatic Progression of Parkinson's Disease |
| Q38003065 | Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease |
| Q28732415 | In vivo evaluation of retinal neurodegeneration in patients with multiple sclerosis |
| Q92315371 | Increased weighting on prior knowledge in Lewy body-associated visual hallucinations |
| Q36152081 | Interocular asymmetry of foveal thickness in Parkinson disease |
| Q40023036 | Lateral geniculate atrophy in Parkinson's with visual hallucination: A trans-synaptic degeneration? |
| Q37146251 | Line bisection in Parkinson's disease: investigation of contributions of visual field, retinal vision, and scanning patterns to visuospatial function |
| Q41863327 | Measuring hemoglobin levels in the optic disc of Parkinson's disease patients using new colorimetric analysis software. |
| Q54984688 | Melanopsin-mediated pupil function is impaired in Parkinson's disease. |
| Q92476232 | Mercury in the retina and optic nerve following prenatal exposure to mercury vapor |
| Q37621388 | Optic Disc and Retinal Nerve Fibre Layer Changes in Parkinson's Disease |
| Q64863053 | Optical Coherence Tomography Findings in Patients of Parkinson's Disease: An Indian Perspective |
| Q28080265 | Optical Coherence Tomography as a Biomarker for Diagnosis, Progression, and Prognosis of Neurodegenerative Diseases |
| Q47221811 | Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases. |
| Q30497714 | Optical coherence tomography (OCT) in optic neuritis and multiple sclerosis |
| Q30499517 | Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration |
| Q38823817 | Optical coherence tomography and neurodegeneration: are eyes the windows to the brain? |
| Q38814500 | Optical coherence tomography angiography: an overview of the technology and an assessment of applications for clinical research |
| Q34238794 | Optical coherence tomography in parkinsonian syndromes |
| Q40143091 | Optical coherence tomography predicts 4-year incident diabetic neuropathy. |
| Q64764728 | Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases |
| Q49761625 | Patterns of Retinal Ganglion Cell Damage in Neurodegenerative Disorders: Parvocellular vs Magnocellular Degeneration in Optical Coherence Tomography Studies |
| Q34432056 | Perimetric and retinal nerve fiber layer findings in patients with Parkinson's disease |
| Q90215258 | Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases |
| Q38007166 | Potential role of retina as a biomarker for progression of Parkinson's disease |
| Q37950421 | Premotor symptoms and early diagnosis of Parkinson's disease |
| Q36057067 | Progressive retinal structure abnormalities in multiple system atrophy |
| Q44317380 | Remodeling of the fovea in Parkinson disease. |
| Q52882599 | Retinal Tissue Thickness is Reduced in Diabetic Peripheral Neuropathy. |
| Q50642694 | Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study. |
| Q48196143 | Retinal and optic nerve evaluation by optical coherence tomography in adults with obstructive sleep apnea-hypopnea syndrome (OSAHS). |
| Q91936690 | Retinal correlates of neurological disorders |
| Q33902900 | Retinal degeneration in progressive supranuclear palsy measured by optical coherence tomography and scanning laser polarimetry |
| Q42933161 | Retinal layer segmentation of macular OCT images using boundary classification |
| Q39608505 | Retinal nerve changes in patients with tremor dominant and akinetic rigid Parkinson's disease |
| Q48186619 | Retinal nerve fiber layer structure abnormalities in patients with Neuro-Behcet's disease |
| Q43471692 | Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease |
| Q34486617 | Retinal nerve fibre layer loss in hereditary spastic paraplegias is restricted to complex phenotypes |
| Q92936887 | Retinal texture biomarkers may help to discriminate between Alzheimer's, Parkinson's, and healthy controls |
| Q53236392 | Retinal thickness profile of individuals with diabetes. |
| Q36927871 | Retinal thinning in Gaucher disease patients and carriers: results of a pilot study |
| Q53255260 | Retinal tissue thickness in type 1 and type 2 diabetes. |
| Q37591956 | Retinopathy in Parkinson Disease |
| Q35661238 | Scanning laser polarimetry and spectral domain optical coherence tomography for the detection of retinal changes in Parkinson's disease |
| Q45293191 | Spectral-Domain Optical Coherence Tomography as a Potential Biomarker in Huntington's Disease |
| Q39360892 | The Retina in Multiple System Atrophy: Systematic Review and Meta-Analysis. |
| Q39449147 | The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma |
| Q34298350 | The optic nerve: a "mito-window" on mitochondrial neurodegeneration |
| Q38594857 | The relevance of pre-motor symptoms in Parkinson's disease |
| Q38061012 | The retina as a window to the brain-from eye research to CNS disorders |
| Q41683709 | The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain |
| Q34625918 | Unbiased approaches to biomarker discovery in neurodegenerative diseases |
| Q36764796 | Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients |
| Q90537022 | Validation of Optical Coherence Tomography Retinal Segmentation in Neurodegenerative Disease |
| Q38171441 | Venturing into the no-man's land of the retina in Parkinson's disease |
| Q36883794 | Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study |
| Q26740467 | Visual dysfunction in Parkinson's disease |
| Q36908647 | Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings |
| Q52772081 | [Retinal imaging of the macula and optic disc in neurodegenerative diseases]. |
Search more.